NACO allocation for HIV/AIDS in 2026–27

The National AIDS Control Organisation (NACO), which runs India’s HIV/AIDS programs, has been allocated ₹2,400 crore for FY 2026–27.

This is a modest increase compared to last year’s allocation of ₹2,300 crore, reflecting the government’s continued commitment to HIV prevention, testing, and treatment.

The funding supports:

• Antiretroviral therapy (ART) centers across India

• Awareness and prevention campaigns targeting high-risk groups

• Community-based support programs for people living with HIV

• Integration of HIV services with broader National Health Mission (NHM) initiatives.

  So, while HIV isn’t listed as a standalone headline item in the Finance Minister’s speech, the detailed expenditure statement confirms that NACO’s budget has been slightly increased this year.

   

  Key Notes

   

• The largest share goes to ART drugs and treatment centers, reflecting India’s focus on universal access to life-saving medication.

• Testing and prevention remain strong priorities, especially in rural and underserved areas.

• Community-based programs are funded to reduce stigma and improve adherence to treatment.

• Research funding ensures India continues tracking HIV trends and innovating in prevention strategies.

• This allocation shows a balanced approach: treatment, prevention, awareness, and research all receive attention, with treatment taking the lion’s share.